GCPL Records Marginal Decline In Profit in Q4 Profit after tax stood at INR 363.24 crore for the period under review compared with INR 365.84 in the year-ago period

By Shrabona Ghosh

Opinions expressed by Entrepreneur contributors are their own.

You're reading Entrepreneur India, an international franchise of Entrepreneur Media.

Godrej Twitter

FMCG company Godrej Consumer Products Ltd (GCPL) on Thursday reported a marginal decline in its consolidated profit after tax (PAT) for the quarter ended 31 March 2022 . The PAT stood at INR 363.24 crore for the period under review compared with INR 365.84 crore in the year-ago period.

Consolidated total revenue from operations during the quarter stood at INR 2,915.82 crore compared with INR 2,730.74 crore in the same period a year ago.

"We delivered a weak performance in Q4 FY 2022. Overall sales grew by 7 per cent and our full year sales grew in double-digits. However, this growth was driven by pricing. We continue to believe that with the relatively non-discretionary, mass pricing of our portfolio and very good performance on market shares, volume growth will return in the medium term," said Sudhir Sitapati, managing director and CEO of GCPL.

"From a category perspective, we saw a strong performance in personal care, which grew by 18 per cent. Home care delivered a weak performance and declined by 7 per cent. From a geography perspective, India grew at 9 per cent. We continue to have a healthy balance sheet and our net debt to equity ratio continues to come down. We are on a journey to reduce inventory and wasted cost and are deploying this to drive profitable and sustainable volume growth across our portfolio through category development," Sitapati added.

As part of a larger plan for a digitally-led business transformation, GCPL has announced two senior level appointments of Rajesh Sethuraman as chief executive officer of ASEAN and Vijay Kannan as the head of business transformation and digital.

GCPL peer ITC in Q4 recorded an increase of 12 per cent in its consolidated net profit. Similarly, despite inflation, HUL's net profit rose 8 per cent for the quarter ended 31 March, 2022. However, Dabur India's Q4 PAT slipped 22 per cent.

Shrabona Ghosh

Correspondent

A journalist with a cosmopolitan mindset. I lead a project called 'Corporate Innovations' wherein I cover corporates across verticals and try to tell stories on innovations. Apart from this, I write industry pieces on FMCGs, auto, aviation, 5G and defense. 
Business Ideas

70 Small Business Ideas to Start in 2025

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2025.

Finance

Fintechs Invest in Making Cross Border Payments More Efficient

According to some reports, the global cross-border payments market was valued at USD 181.9 trillion in 2022, and is projected to reach USD 356.5 trillion by 2032, growing at a CAGR of 7.3 per cent from 2023 to 2032.

News and Trends

India's Online Gaming Boom: A USD 9.1 Billion Industry in the Making

Web3 gaming has potential, but experts believe it's not fully ready yet. "Web3's biggest challenge is balancing in-game economies. If real-world assets are involved, mistakes in inflation and deflation can be catastrophic," Saikat Mondal, SVP-Strategy & M&A at Nazara

News and Trends

India Has the Edge Over China, Top Destination for Investors in the Long Term: Report

India is positioned as the leading growth story of the 21st century, having strategic advantages over China and other emerging markets and is a top destination for equity investments, said a report by Bay Capital, an India-focused investment management firm.

Leadership

The Power of Thought in Shaping Your Success — How Mindset Drives Your Circumstances

Your mindset can either propel you to success or hold you back in mediocrity. Here's how you can start taking control of your thoughts to improve your business outcomes.

News and Trends

Narayana Health, W Health Ventures, and 2070 Health Launch Everhope Oncology with USD 10 Mn Funding to Transform Cancer Care

With an initial USD 10 million seed funding, Everhope will establish medical and surgical oncology facilities in Delhi and Mumbai, with plans to expand to 10 cities over the next three years.